4.7 Article

Generalizable design parameters for soluble T cell receptor-based T cell engagers

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemical Research Methods

T cell antigen discovery

Alok V. Joglekar et al.

Summary: T cells respond to threats by recognizing short peptide antigens presented on MHC proteins using T cell receptors, which determines their function in disease. Recent method developments have made progress in T cell antigen discovery, but there are still challenges to overcome.

NATURE METHODS (2021)

Article Multidisciplinary Sciences

Targeting a neoantigen derived from a common TP53 mutation

Emily Han-Chung Hsiue et al.

Summary: An antibody highly specific to the most common TP53 mutation has been identified and converted into an immunotherapeutic agent. Despite low complex density on the cancer cell surface, the bispecific antibody effectively activates T cells to lyse cancer cells expressing the neoantigen. This approach may be used to target cancers with mutations that are difficult to target conventionally.

SCIENCE (2021)

Article Medicine, General & Internal

Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma

Paul Nathan et al.

Summary: The randomized trial of tebentafusp for metastatic uveal melanoma showed a higher 1-year overall survival rate among patients who received tebentafusp compared to those who received the investigator's choice of therapy, indicating superior efficacy.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Oncology

Dichotomous impact of affinity on the function of T cell engaging bispecific antibodies

Mathilde Poussin et al.

Summary: This study investigates the impact of T cell engaging BsAbs with different affinities on potency, efficacy, and immunomodulatory receptors/ligands. The results suggest that lower CD3 affinity may improve therapeutic index and combining T cell checkpoint inhibition and co-stimulation can significantly enhance efficacy against tumors.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Review Immunology

Emerging Approaches for Regulation and Control of CAR T Cells: A Mini Review

Laerke J. B. Brandt et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

Computational stabilization of T cell receptors allows pairing with antibodies to form bispecifics

Karen Froning et al.

NATURE COMMUNICATIONS (2020)

Article Oncology

Perspective: Designing T-Cell Engagers With Better Therapeutic Windows

Omid Vafa et al.

FRONTIERS IN ONCOLOGY (2020)

Review Oncology

T cell-engaging therapies - BiTEs and beyond

Maria-Elisabeth Goebeler et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

Review Oncology

Novel TCR-based biologics: mobilising T cells to warm 'cold' tumours

Kate L. Lowe et al.

CANCER TREATMENT REVIEWS (2019)

Review Immunology

T cell receptor-based cancer immunotherapy: Emerging efficacy and pathways of resistance

Smita S. Chandran et al.

IMMUNOLOGICAL REVIEWS (2019)

Editorial Material Biochemistry & Molecular Biology

Fludarabine and neurotoxicity in engineered T-cell therapy

Kate L. Lowe et al.

GENE THERAPY (2018)

Review Multidisciplinary Sciences

CAR T cell immunotherapy for human cancer

Carl H. June et al.

SCIENCE (2018)

Article Biotechnology & Applied Microbiology

Transient and stable CHO expression, purification and characterization of novel hetero-dimeric bispecific IgG antibodies

Yashas Rajendra et al.

BIOTECHNOLOGY PROGRESS (2017)

Review Immunology

Understanding the structural dynamics of TCR-pMHC interactions

Itamar Kass et al.

TRENDS IN IMMUNOLOGY (2014)

Review Pharmacology & Pharmacy

Targeting C-type lectin receptors with multivalent carbohydrate ligands

Bernd Lepenies et al.

ADVANCED DRUG DELIVERY REVIEWS (2013)

Article Oncology

Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1-and LAGE-1-positive tumors

Emmet McCormack et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)

Review Oncology

The blockade of immune checkpoints in cancer immunotherapy

Drew M. Pardoll

NATURE REVIEWS CANCER (2012)

Article Biochemistry & Molecular Biology

An Unfolded CH1 Domain Controls the Assembly and Secretion of IgG Antibodies

Matthias J. Feige et al.

MOLECULAR CELL (2009)

Article Immunology

The kinetic-segregation model: TCR triggering and beyond

Simon J. Davis et al.

NATURE IMMUNOLOGY (2006)

Article Biotechnology & Applied Microbiology

Directed evolution of human T-cell receptors with picomolar affinities by phage display

Y Li et al.

NATURE BIOTECHNOLOGY (2005)

Article Multidisciplinary Sciences

Crystal structure of a human CD-ε/δ dimer in complex with a UCHT1 single-chain antibody fragment

KL Arnett et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Multidisciplinary Sciences

Crystal structure of the human T cell receptor CD3εγ heterodimer complexed to the therapeutic mAb OKT3

L Kjer-Nielsen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)